Showing 2611-2620 of 3315 results for "".
- BVI Expands IOL Capacity with New Facility in Belgiumhttps://modernod.com/news/bvi-expands-iol-capacity-with-new-facility-in-belgium/2481738/BVI has announced the opening of a new facility in Liège, Belgium that increases the company's IOL business capacity. BVI says the facility will unlock new growth opportunities while reinforcing the company’s environmental, social, and governance (ESG) leaders
- Smartlens Closes $6.1 Million Series A Financing to Advance miLens Devicehttps://modernod.com/news/smartlens-closes-61-million-series-a-financing-to-advance-milens/2481727/Smartlens has closed an oversubscribed $6.1 million Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal IOP. The miLens device is an electronics free soft contact lens that uses mi
- Heidelberg Engineering Names Hartmut Becker Head of Global Saleshttps://modernod.com/news/heidelberg-engineering-names-hartmut-becker-head-of-global-sales/2481710/Heidelberg Engineering has introduced Hartmut Becker as new Head of Global Sales, effective April 2023. In his new role, he will be leading the company’s sales and distribution activities across the group, and is responsible for supporting Heidelberg Engineering’s direct sub
- Bausch + Lomb Acquires Blink OTC Eye Drops from J&J Visionhttps://modernod.com/news/bausch-lomb-acquires-blink-eye-drops-from-jj-vision/2481709/The latest in a string of major moves by Bausch + Lomb, the company announced it is purchasing the Blink product line of eye and contact lens
- iOR Publishes Ophthalmic Office-Based Surgery Safety Studyhttps://modernod.com/news/ior-publishes-ophthalmic-office-based-surgery-safety-study/2481693/Office-based lens surgery can be performed safely, with adverse event rates similar to or lower than those in the published literature, according to a study published by iOR Partner
- Luminopia Raises Money to Support Full Commercial Rollout of Amblyopia Therapeutichttps://modernod.com/news/luminopia-raises-money-to-support-full-commercial-rollout-of-amblyopia-therapeutic/2481692/Luminopia announced it has raised an additional $16 million in new capital to support the full commercial rollout later this year of the company’s lead product, Luminopia, a software-based therapeutic for amblyopia, the leading cause of vision loss among children. Luminopia w
- The International Agency for the Prevention of Blindness (IAPB) Welcomes Over 300 International Delegates to Singaporehttps://modernod.com/news/the-international-agency-for-the-prevention-of-blindness-iapb-welcomes-over-300-international-delegates-to-singapore/2481690/The International Agency for the Prevention of Blindness (IAPB) has welcomed more than 300 delegates to Singapore for its "2030 IN SIGHT LIVE" event. Hosted in partnership with the Singapore Eye Research Institute (SERI), the event gathers experts and thought leaders from eye
- FDA Rejects Aldeyra's NDA for Rare Eye Cancer Drug ADX-2191https://modernod.com/news/fda-rejects-aldeyras-nda-for-rare-eye-cancer-drug-adx-2191/2481684/The FDA issued a Complete Response Letter to Aldeyra Therapeutics for the NDA of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate for the treatment of primary vitreoretinal lymphoma (PVRL). Although no safety or manufacturing issues with ADX-2191 w
- Alcon to Showcase Innovations for Eye Care Practice Success at 2023 Optometry’s Meetinghttps://modernod.com/news/alcon-to-showcase-innovations-for-eye-care-practice-success-at-2023-optometrys-meeting/2481682/Alcon will showcase innovations from advances in the reusable lens space to digital offerings at Optometry’s Meeting, the American Optometric Association (AOA) annual conference taking place June 21-24 in Washington, D.C. Through interactive events, Q&A’s, live demonstrations, and
- New Nerve Insights Could Someday Help Heal Certain Types of Blindness and Paralysishttps://modernod.com/news/new-nerve-insights-could-someday-help-heal-certain-types-of-blindness-and-paralysis/2481666/A team of UConn School of Medicine researchers report in the journal Development that at least a small population of nerve cells exist in everyone tha